More Stories

Informist, Tuesday, Feb. 10, 2026

 

Please click here to read all liners published on this story

--Apollo Hosp Oct-Dec consol net profit INR 5.02 bln 
--Analysts saw Apollo Hosp Oct-Dec consol net profit at INR 4.69 bln 
--Apollo Hosp Oct-Dec consol revenue INR 64.77 bln 
--Analysts saw Apollo Hosp Oct-Dec consol revenue at INR 63.01 bln 
--Apollo Hosp Oct-Dec consol PAT INR 5.02 bln vs INR 3.72 bln yr ago 
--Apollo Hosp Oct-Dec consol revenue INR 64.77 bln vs INR 55.27 bln yr ago 
--Apollo Hosp to pay INR 10 per share interim dividend 
--Apollo Hosp interim dividend record date Feb 16 
--Apollo Hosp Apr-Dec consol PAT INR 14.12 bln vs INR 10.56 bln yr ago 
--Apollo Hosp Apr-Dec consol revenue INR 186.23 bln vs INR 162.02 bln yr ago 
--Apollo Hosp Q3 consol EBITDA INR 9.65 bln, up 27% on year 
--Apollo Hosp Q3 consol health svcs sales INR 32.25 bln vs INR 28.03 bln 
--Apollo Hosp Q3 digital health, pharma ops sales INR 28 bln vs INR 24 bln 
--Apollo Hosp Q3 consol retail health, diagnostics sales INR 4.67 bln 
 

 

By Arya S. Biju

 

MUMBAI – Apollo Hospitals Enterprise Ltd. reported better-than-expected earnings for the December quarter, with both top line and bottom line beating analysts' estimates. The company's top line for the quarter grew at its fastest pace in 11 quarters, supported by strong sales growth across all three business verticals. The company's total expenses for the reporting quarter rose slower than its sales, supporting its bottom line. 

 

Apollo Hospitals' consolidated net profit for the quarter grew 35% on year and a shade over 5% sequentially to INR 5.02 billion. This was better than the INR 4.69 billion estimated by the Street. The company's bottom line for the quarter was impacted by a one-time cost of INR 192 million related to the implementation of the new Labour Codes. Adjusted for the one-time cost, the company would have reported a net profit of INR 5.22 billion. 

 

The company's consolidated revenue for the quarter grew by a little over 17% on year and by around 3% sequentially to INR 64.77 billion. This was also better than the INR 63.01 billion revenue expected by the Street. Meanwhile, the company's other income for the quarter fell over 17% on year and over 3% on quarter to INR 528 million.  

 

The company's consolidated earnings before interest, taxes, depreciation, and amortisation for the quarter grew 27% on year to INR 9.65 billion. "Q3FY26 (Oct-Dec) reflects the fundamental strength and clinical depth of Apollo's integrated care model," Prathap C Reddy, chairman of Apollo Hospitals Enterprise, said in a release. "This quarter, sustained investments in advanced clinical capability translated into meaningful progress across key specialities from Apollo OMR completing 150 robotic joint replacement surgeries in its first 150 days, to the expansion of our stroke care network in Chennai with nine advanced stroke labs, strengthening rapid access care and outcomes," Reddy said. 

Apollo Hospitals' total expenses for the quarter grew around 16% on year to INR 58.44 billion, lower than the over 17% on-year growth in net sales. Its expenses related to the purchase of stock-in-trade grew over 16% on year to INR 26.63 billion in the reporting quarter. The company's other expenses for the quarter rose over 17% on year to INR 13.81 billion and the cost of raw materials grew 19% on year to INR 7.45 billion. Its tax expense for the quarter was INR 1.66 billion, up around 6% on year but down over 8% sequentially. 

 

SEGMENT PERFORMANCE 

Consolidated revenue from the company's healthcare services segment grew over 15% on year to INR 32.25 billion, while the segment's consolidated profit grew over 17% on year to INR 6.24 billion. The segment's EBITDA for the quarter was INR 7.90 billion, up 18% on year and its EBITDA margin was 24.8%. 

 

As of Dec. 31, Apollo Hospitals had 8,072 operating beds across its network, excluding Apollo Health & Lifestyle Ltd. and managed beds, the company said in the press release. Overall hospital occupancy was 67%, down from 68% in the corresponding quarter a year ago. 

 

Consolidated revenue from the retail health and diagnostics business grew around 20% on year to INR 4.67 billion in the December quarter. The segment's consolidated net profit for the quarter more than tripled on year to INR 117 million. Consolidated revenue from its digital health and pharmacy distribution business rose over 20% on year to INR 28.28 billion and its net profit for the quarter more than doubled on year to INR 1.08 billion. 

 

In the nine months to December, Apollo Hospitals reported a consolidated net profit of INR 14.12 billion, up nearly 34% on year. Its revenue for the period was INR 186.23 billion, up 15% on year. Its consolidated EBITDA for Apr-Dec grew over 22% on year to INR 27.58 billion. 

 

The company's subsidiary, Imperial Hospital and Research Centre Ltd., has acquired 648,468 shares in Belenus Champion Hospitals Pvt. Ltd. from the existing shareholders at a price of INR 136.14 per share, aggregating to a total value of INR 88.28 million. The total cost of the acquisition, including settlement of liabilities, was INR 1.65 billion, Apollo Hospitals said in a separate exchange filing. 

 

Belenus runs a 125-bed hospital in Bengaluru, which is currently being upgraded and expanded and is set to reopen by the June quarter of 2026-27 (Apr-Mar). With this, the hospital's capacity will be expanded to 175 beds at an overall cost of INR 3 billion, including the initial acquisition cost of INR 1.65 billion, Apollo Hospitals said. 

 

Tuesday, Apollo Hospitals' shares closed 0.1% higher at INR 7,219 on the National Stock Exchange. The company announced the December quarter results after market hours.   End 

 

Edited by Saji George Titus

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

 

Informist Media Tel +91 (22) 6985-4000

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2026. All rights reserved.